Table 3.
CR/PR | SD/PD | |
---|---|---|
TFI ≥ 6 months | 10 (42%)a | 14 (58%) |
TFI < 6 months | 0 (0%) | 16 (100%)a |
Forty-two percent (10 out of 24 cases) of the patients whose TFI was equal to or longer than 6 months exhibited sensitivity to second-line chemotherapy; however, all cases whose TFI was shorter than 6 months were resistant to second-line chemotherapy. This association was statistically significant (P = 0.0026 by Fisher’s exact test)
TFI treatment-free interval, CR complete response, PR partial response, SD stable disease, PD progressive disease
a P = 0.0026